Recombinant Human CD201/PROCR, N-His from ProteoGenix; catalogue ARO-P13001; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human CD201, also known as PROCR, is a protein that plays a crucial role in the regulation of blood coagulation and inflammation. It is a transmembrane glycoprotein that is expressed on the surface of endothelial cells and acts as a receptor for the anticoagulant protein C. In this article, we will explore the structure, activity, and applications of Recombinant Human CD201/PROCR.
Recombinant Human CD201/PROCR is a 72 kDa protein consisting of 484 amino acids. It is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain contains two epidermal growth factor (EGF)-like domains and six tandemly repeated sushi domains. These domains are responsible for the binding of protein C and other ligands. The transmembrane domain anchors the protein to the cell membrane, while the cytoplasmic domain is involved in intracellular signaling.
The main function of Recombinant Human CD201/PROCR is to enhance the activity of protein C, a natural anticoagulant, by facilitating its activation. This is achieved through the binding of protein C to the EGF-like domains of CD201/PROCR, which triggers a conformational change in protein C and exposes its active site. Activated protein C then inhibits the coagulation cascade by inactivating factors Va and VIIIa. This activity of CD201/PROCR is essential for maintaining the balance between coagulation and anticoagulation in the body.
In addition to its anticoagulant activity, CD201/PROCR also has anti-inflammatory properties. It has been shown to inhibit the production of pro-inflammatory cytokines and chemokines, and to promote the production of anti-inflammatory molecules. This makes CD201/PROCR an important regulator of the inflammatory response in various diseases.
Recombinant Human CD201/PROCR has a wide range of potential applications in the field of medicine. One of the most significant applications is in the treatment of thrombotic disorders. Mutations in the gene encoding CD201/PROCR have been associated with an increased risk of thrombosis. Recombinant Human CD201/PROCR can be used as a therapeutic agent to restore the balance between coagulation and anticoagulation in these patients.
Another potential application of Recombinant Human CD201/PROCR is in the treatment of inflammatory diseases. As mentioned earlier, CD201/PROCR has anti-inflammatory properties, which make it a promising target for the development of novel anti-inflammatory drugs. Recombinant Human CD201/PROCR can also be used in combination with other anti-inflammatory agents to enhance their effectiveness.
Moreover, Recombinant Human CD201/PROCR has been studied for its potential role in cancer therapy. It has been shown to inhibit the growth and metastasis of certain types of cancer cells, making it a potential target for the development of anti-cancer drugs.
In summary, Recombinant Human CD201/PROCR is a multifunctional protein with important roles in blood coagulation and inflammation. Its structure, activity, and potential applications make it a promising therapeutic target for various diseases. Further research on this protein will help us better understand its function and explore its potential in the development of new treatments for a variety of medical conditions.
ProteoGenix catalogue number ARO-P13001. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 24.33 kDa; Fragment: Ser18-Ser210; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
